Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Are anticoagulants still indicated in pulmonary arterial hypertension?
Horst Olschewski
*
,
Stuart Rich
*
Corresponding author for this work
Medicine, Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Are anticoagulants still indicated in pulmonary arterial hypertension?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Pulmonary Hypertension
100%
Anticoagulant
100%
Diseases
36%
Anticoagulation
36%
Warfarin
18%
Thrombosis
18%
Peripheral Vasodilating Agent
18%
Direct Oral Anticoagulant
18%
Exercise Tolerance
9%
Overall Survival
9%
Observational Study
9%
Procoagulant
9%
Vasoconstriction
9%
Vitamin K Antagonist
9%
Artery Intima Proliferation
9%
Clinical Trial
9%
Vascular Remodeling
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Pulmonary Hypertension
100%
Disease
36%
Direct Oral Anticoagulant
18%
Peripheral Vasodilating Agent
18%
Thrombosis
18%
Warfarin
18%
Observational Study
9%
Clinical Trial
9%
Overall Survival
9%
Vascular Remodeling
9%
Procoagulant
9%
Antivitamin K
9%
Artery Intima Proliferation
9%
Inflammation
9%
Keyphrases
Intraluminal Thrombosis
11%
Drug-induced Pulmonary Hypertension
11%